Agnes BoschUniversitätsklinikum Erlangen1 paperORCID 0000-0001-6952-4660 ↗OpenAlex ↗PapersEndocrinology, Diabetes & MetabolismHuman trial·1 OctEffects of SGLT-2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine-N-Oxide in Patients With Type-2 Diabetes
Endocrinology, Diabetes & MetabolismHuman trial·1 OctEffects of SGLT-2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine-N-Oxide in Patients With Type-2 Diabetes